These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 11057850)

  • 41. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery.
    Scholten DJ; Hoedema RM; Scholten SE
    Obes Surg; 2002 Feb; 12(1):19-24. PubMed ID: 11868291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration.
    Schobess R; Düring C; Bidlingmaier C; Heinecke A; Merkel N; Nowak-Göttl U
    Haematologica; 2006 Dec; 91(12):1701-4. PubMed ID: 17145610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
    N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current primary care practice in the diagnosis and management of patients with suspected venous thromboembolism and prescription of initiation dose of enoxaparin.
    Verhamme P; Motte S; Claes N; Verhaeghe R; Hermans C
    Int Angiol; 2010 Feb; 29(1):58-63. PubMed ID: 20224534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism].
    Nielsen HK; Lassen JF; Ravn HB; Husted SE
    Ugeskr Laeger; 1995 May; 157(20):2835-40. PubMed ID: 7785097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged thromboprophylaxis with enoxaparin in early neurological rehabilitation.
    Lang A; Kienitz C; Wetzel P; Rollnik JD
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):470-5. PubMed ID: 20547551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group.
    Hamulyák K; Lensing AW; van der Meer J; Smid WM; van Ooy A; Hoek JA
    Thromb Haemost; 1995 Dec; 74(6):1428-31. PubMed ID: 8772214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control study.
    Hacobian M; Shetty R; Niles CM; Gerhard-Herman M; Vallurupalli N; Baroletti S; McKean SC; Sonis J; Parasuraman S; Kosowsky JM; Goldhaber SZ
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):21-5. PubMed ID: 19147527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
    Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
    Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.
    Samama CM; Vray M; Barré J; Fiessinger JN; Rosencher N; Lecompte T; Potron G; Basile J; Hull R; Desmichels D;
    Arch Intern Med; 2002 Oct; 162(19):2191-6. PubMed ID: 12390061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Genton E; Hirsh J; Gent M; Sackett D; McLoughlin D; Armstrong P
    N Engl J Med; 1979 Oct; 301(16):855-8. PubMed ID: 384248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis.
    Pini M; Aiello S; Manotti C; Pattacini C; Quintavalla R; Poli T; Tagliaferri A; Dettori AG
    Thromb Haemost; 1994 Aug; 72(2):191-7. PubMed ID: 7831650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
    Klamroth R; Gottstein S; Essers E; Landgraf H
    Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of intravenous enoxaparin for carotid endarterectomy: a prospective randomized pilot trial.
    Assadian A; Knöbl P; Hübl W; Senekowitsch C; Klingler A; Pfaffelmeyer N; Hagmüller GW
    J Vasc Surg; 2008 Mar; 47(3):537-42. PubMed ID: 18234466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years].
    Slunsky R
    Zentralbl Gynakol; 1995; 117(11):598-601. PubMed ID: 8533494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
    Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
    N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of antithrombotic efficacy and haemorrhagic side-effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery.
    Planes A
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S33-5; discussion S37-8. PubMed ID: 8180327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.
    Prins MH; Lensing AW; Brighton TA; Lyons RM; Rehm J; Trajanovic M; Davidson BL; Beyer-Westendorf J; Pap ÁF; Berkowitz SD; Cohen AT; Kovacs MJ; Wells PS; Prandoni P
    Lancet Haematol; 2014 Oct; 1(1):e37-46. PubMed ID: 27030066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of recurrences after deep venous thrombosis: role of low-molecular-weight heparins.
    Pini M
    Semin Thromb Hemost; 1997; 23(1):51-4. PubMed ID: 9156411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.